





The increasing availability of pneumococcal vaccine has gener-
ally decreased the burden of pneumococcal disease among 
at-risk populations, not the least of which are children with 
HIV in southern Africa. However, a recent article in the Journal 
of the American Medical Association raises some concerns about 
the regular use of the vaccine. There has always been a concern 
that routine childhood vaccine using heptavalent pneumococcal 
conjugate vaccine would lead to the emergence and expan-
sion of replacement disease caused by serotypes that are not 
contained in the heptavalent conjugate vaccine.
This study among Alaskan native children suggests that this 
is a very real concern. Rosalyn Singleton and colleagues used 
Alaskan statewide, longitudinal, population-based laboratory 
surveillance of invasive Streptococcus pneumoniae infections from 
1 January 1999 to 31 December 2006. They found that in the first 
3 years after the introduction of the vaccine, overall invasive 
pneumococcal disease decreased by 67% among Alaskan native 
children younger than 2 years. However, between 2001 and 
2003 and 2004 and 2006, there was an 82% increase in invasive 
disease among these children. And, since 2004, the invasive 
pneumococcal disease rate caused by non-vaccine serotypes in-
creased by 140% compared with the pre-vaccine period. During 
the same period, there was a 96% decrease in heptavalent sero-
type disease, and no significant increase in non-vaccine disease 
among non-native Alaskan children younger than 2 years. 
The authors conclude that Alaskan native children are 
experiencing replacement invasive pneumococcal disease with 
serotypes not covered by heptavalent pneumococcal conjugate 
vaccine. This shows how important it is to carry out ongoing 
surveillance and to develop expanded valency vaccines.
Singleton RJ, et al. JAMA 2007; 297: 1784-1792.
Class of antiretroviral and risk of myo-
cardial infarction
The DAD study group have previously reported a demon-
strated association between combination antiretroviral therapy 
and the risk of myocardial infarction. However, it was not clear 
whether this association differed according to the class of drug. 
The group conducted a study, published recently in the New 
England Journal of Medicine, that investigated the association of 
cumulative exposure to protease inhibitors and non-nucleoside 
reverse transcriptase inhibitors with the risk of myocardial 
infarction.
They looked at the data they had collected, starting in 
February 2005, from their prospective study of 23 437 patients 
infected with HIV. They recorded the incidence of myocardial 
infarction during the follow-up period and looked at the associ-
ations between myocardial infarction and exposure to protease 
inhibitors or non-nucleoside reverse transcriptase inhibitors. 
They found that 345 patients had a myocardial infarction 
during the follow-up period. The incidence of myocardial 
infarction was increased in those patients who were exposed 
to protease inhibitors for more than 6 years. This effect was 
not seen in patients who were not exposed to protease inhibi-
tors and was not associated with exposure to non-nucleoside 
reverse transcriptase inhibitors, although patients were not 
exposed to this class of drug for as long. They conclude that 
it is exposure to protease inhibitors that increases the risk of 
myocardial infarction and that this is only partly explained by 
the concomitant dyslipidaemia. 
DAD study group. NEJM 2007; 356: 1723-1735.
Annual treatment for postmenopausal 
osteoporosis
With regular scare stories about the risks of hormone replace-
ment therapy hitting the popular press and the concomitant 
scientific articles in the medical literature, I suspect that fewer 
postmenopausal women will be turning to hormone replace-
ment therapy to deal with the often very distressing symptoms 
associated with menopause. This will inevitably lead to an 
increase in the burden of osteoporosis, so it is good to know 
that there are alternatives that may reduce this.
Dennis Black and colleagues, writing in the New England 
Journal of Medicine, assessed the effects of annual infusions of 
zolendronic acid on fracture risk over a 3-year period. A single 
infusion of zolendronic acid decreases bone turnover and 
improves bone density at 12 months in postmenopausal women 
with osteoporosis. 
They looked at 3 889 women, with an average age of 73 years, 
who were randomly assigned to receive a single 15-minute 
infusion of 5 mg of zolendronic acid and 3 876 women who 
were assigned to receive placebo at baseline, at 12 months and 
at 24 months. The patients were followed up for 36 months. 
They found that treatment with zolendronic acid reduced the 
risk of morphometric vertebral fracture by 70% during the 3-
year period compared with placebo and reduced the risk of hip 
fracture by 41%. Nonvertebral fracture, clinical fractures and 
clinical vertebral fracture were all reduced by 25%, 33% and 
77% respectively. Zolendronic acid was also associated with a 
significant improvement in bone mineral density and bone me-
tabolism markers. Adverse events, including changes in renal 
function, were similar in both groups. But, serious atrial fibrilla-
tion did occur more frequently in the zolendronic acid group.
The authors conclude that an annual infusion of zolendronic 
acid during the 3-year study period did significantly reduce 
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the risk of vertebral, hip and other fractures. Now all we need 
is an annual infusion of something that reduces hot flushes to a 
manageable level.
Black DM, et al. NEJM 2007; 356: 1809-1822.
Obesity from childhood to adulthood
It is generally accepted that a fat child has a high risk of be-
coming a fat adult. But is the relationship absolute? A recent 
Australian study suggests not. Alison Venn and colleagues 
followed a cohort of 8 498 Australian school children through to 
adulthood, starting the study in 1985. The children were aged 
between 7 and 15 years and participated in the 1985 Austra-
lian Schools Health and Fitness Survey. They then followed 
up 2 208 men and 2 363 women who completed a follow-up 
questionnaire when they were aged between 24 and 34 years in 
2001 - 2005.
Height and weight were measured in 1985 and self-reported 
at follow-up. The authors checked the accuracy of self-reported 
data in 1 185 participants. Overweight and obesity were defined 
according to international standard definitions for body mass 
index (BMI): in adults, a BMI of 25 - 29.9 and more than 30 
respectively. 
They found that, among participants who had both baseline 
and follow-up data, the prevalence of overweight and obesity 
in childhood was 8.3% and 1.5% in boys and 9.7% and 1.4% 
in girls, respectively. At follow-up, the prevalence was 40.1% 
and 13.0% in men and 19.7% and 11.7% in women. The relative 
risk of becoming obese in adulthood was significantly higher 
for those who had been obese as children compared with those 
who were a healthy weight. The proportion of adult obesity 
attributed to childhood obesity was 6.4% in men and 12.6% in 
women. So, although obesity in childhood is a strong predictor 
of obesity later in life, most people who become obese as adults 
were actually a healthy weight as children. 




Radiographic Anatomy and Interpretation of  the Chest and 
Pulmonary System. WHO. Pp. v  +  146. Illustrated. CHF40/US$36.
WHO. 2006. ISBN 92 4 154677 8.
In even the most technically advanced radiology departments, 
it is estimated that 70 - 80% of clinically relevant questions 
can be answered by plain radiographs and ultrasound. This 
prompted the World Health Organization to produce a series of 
basic radiology texts for use by health care workers in develop-
ing economies. This book is thus one in a series. 
Authored by the eminent Micheal Ellis and Christopher 
Flower, it is a short, lucid text on adult chest radiology, with 
over 400 high-quality images. It offers an approach to plain film 
interpretation and covers aspects of radiographic technique 
and anatomy, together with radiological signs and patterns. 
Later sections include radiological pathology of the lung, 
mediastinum, pleura, chest wall and heart as well as a short 
chapter on chest trauma. The book represents a rich seam of 
radiological ‘pearls’ that assist in chest interpretation. The 
experience of the authors is evident on every page.   
As a text for developing countries, more attention could 
have been afforded the lateral chest radiograph – only 14 such 
images are included. In this regard the book reflects the trend 
in developed countries, where the lateral projection is not part 
of the routine chest evaluation. However, a sound knowledge 
of anatomy, signs and patterns on the lateral chest radiograph 
is important in developing countries with a high prevalence 
of pulmonary tuberculosis and human immuno-virus (HIV) 
infection.  This book does not address this need. Sections on 
paediatrics and the chest radiographic features of HIV infection 
are not included, but would be worthy additions.
Not an exhaustive text, it requires some radiology 
background. It could thus be  profitably used as a synopsis 
by radiology trainees, experienced radiographers wishing 
to enhance their interpretation skills, qualified radiologists 
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